Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
June 08, 2024 at 15:20 PM EDT
Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent BioPharma.
